← All organizations

Immune Targeting Systems Ltd

For profit

Highest phase reached

Phase 2

First clinical trial

Aug 1, 2010

Last known activity

Jan 1, 2014

Acquired by Altimmune, Inc. on Feb 17, 2015

Timeline

2000s

  1. Jun 1, 2003

    Immune Targeting Systems Ltd— Founded

2010s

  1. Feb 17, 2015

    Altimmune, Inc.— Acquired By

Drugs by trial phase (2 distinct, 4 trials)

Phase 2 (1 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Recent trials (4)

Details

Founded
London, GB Jun 1, 2003
Last known activity
Jan 1, 2014